Search

everythinglearnresearchcommunity

for

Search:↓

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Betamethasone dipropionate lotion is more effective than minoxidil solution for treating Alopecia Areata.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Less AgNOR protein production is linked to hair loss.

The modified hair loss classification is more detailed but less user-friendly.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

Newer contraceptives with less androgenic progestins may reduce female hair loss.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

Removing PLCg1 from skin cells caused thicker oil glands and less hair in mice.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

The study suggests silicon might be important for healthy hair, as less silicon was found in people with hair loss.

Scalp tonics are popular for stress-related hair loss, but minoxidil is used less due to side effects and inconvenience.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

People in Moldova have less selenium in their hair than recommended, which may contribute to hair loss.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Follicular Unit Hair Transplantation has become a less invasive procedure with natural results, suitable for certain adults with hair loss.

Hair loss can make people feel less attractive and confident, leading them to try many treatments.

Hair loss is linked to eating less soy, having lower blood vanadium, and a specific genetic variation in Taiwanese communities.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.